This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
XtalPi has entered a strategic partnership with CK LifeSciences for artificial intelligence (AI)-driven tumour vaccine research and development (R&D). The post XtalPi and CK LifeSciences to develop AI-driven tumour vaccine R&D platform appeared first on Pharmaceutical Technology.
The Indian lifesciences sector is making strides by integrating quantum computing, artificial intelligence (AI), machine learning (ML), advanced analytics, big data, internet of things (IoT) and blockchain into their research and development efforts.
As the Union Budget approaches, the lifesciences sector anticipates substantial support to enhance innovation and investment in the development of new chemical entities (NCEs) and new biological entities (NBEs). The lifesciences sector in India has shown remarkable resilience […]
The expansion will also contribute to building the province of Ontarios position as a global hub for lifesciences and biotechnology. The acquisition was one of the largest research investments in a Canadian biotech firm. Since 2018, the province has secured over $6 billion in new investments in the lifesciences industry.
Research from Everest Group shows how lifesciences leaders are investing in process mining to speed time-to-market, improve regulatory compliance and drive innovation.
Viatris has signed definitive agreements to acquire Oyster Point Pharma and Famy LifeSciences in a deal totalling nearly $700m-$750m in cash to establish an ophthalmology franchise. Famy LifeSciences has an ophthalmology portfolio that complements Viatris. Viatris plans to finance these purchases in cash.
This prestigious acknowledgment places Cloudbyz among the top-performing companies globally, known for delivering scalable and intuitive CTMS solutions that empower clinical research teams. Our mission is to enable faster, more efficient trials, ultimately supporting the delivery of life-saving therapies.”
In the lifesciences sector, one country is significantly outstripping others for FDI. Data shows that almost 40% of all lifesciences subsidiaries are located in the US. After all, around a third of the world’s leading lifesciences corporations have their headquarters in the country. Industry clusters.
Two drugs developed by Wave LifeSciences didn't appear to have an effect on disease-causing proteins, another setback for Huntington's research after disappointing results last week from Roche and Ionis.
GSK has entered a strategic partnership with Wave LifeSciences to progress the discovery and development of oligonucleotide therapies for new genetic targets. The discovery alliance, with a preliminary research period of four years, will aid GSK in progressing up to eight programmes and Wave to develop up to three programmes.
From the Human Genome Project to contemporary drug development, collaboration is critical to the lifesciences. It is also an important factor in the success of lifesciences clusters, where a high concentration of pharmaceutical or medical device companies can all be found in one district, city or region.
It is no secret that Canada boasts a strong and competitive lifesciences sector. Within Canada, one province has often stood out as the place to be for cutting-edge lifesciences innovation. These factors have combined to make Ontario a leading force for medical research and innovation. Again, this is nothing new.
Trends in Psoriasis Research: Biologics, Biosimilars and New Therapies Recent innovations in biologics and biosimilars have transformed psoriasis care. The Psoriasis Diet Diet has long been an area of research as a potential factor in managing psoriasis.
Discover the role of GenAI in lifesciences in 2024. Explore how artificial intelligence and machine learning techniques like GenAI are revolutionising drug development, diagnostics, and research. Learn how industry leaders, including Google, are leveraging GenAI to advance healthcare and enhance patient outcomes.
The Abu Dhabi Department of Health (DoH) in the UAE has made a declaration of collaboration with Mass General Brigham’s (MGB) International Center for Genetic Disease (iCGD) to advance lifesciences.
From enabling patient choice during clinical trials to strengthening vital partnerships across the quality ecosystem, connected data will become the lifeblood that enables lifesciences teams to collaborate efficiently and effectively in 2023. The post 6 research and development lifesciences predictions for 2023 appeared first on.
Why Is Patient-Centric Marketing The post Patient-Centric Marketing in the LifeScience Industry: Putting the Focus on Patient Needs appeared first on Pharma Mirror Magazine.
As we step into 2024, the lifesciences continue to evolve at an unprecedented pace, driven by technological innovation, a deeper understanding of human biology and the application of new technologies in areas like drug development and health wearables. These companies are at various stages of research and clinical trials.
Join us as we celebrate a major milestone the 200th episode of the Xtalks LifeScience Podcast! From groundbreaking biotech innovations to exclusive interviews with lifescience industry innovators and leaders, we’ve covered it all. Subscribe to the Xtalks LifeScience Podcast to never miss a new episode.
Consistency is a key factor in any successful lifescience content marketing strategy. By keeping the conversation going, content marketers within the lifescience industry can build trust with their audience and create a loyal following that will continue to engage with their content and products over time.
Another unique challenge in psychiatry trials is the placebo response, which is notably high in mental health research. Rae emphasized the need to empower and enable research sites to accommodate patients rather than patients accommodating study schedules.
The grant is one of the Novo Nordisk Foundation’s largest and will fund a 12-year research collaboration to construct a quantum computer dedicated to the lifesciences.
This Act is poised to significantly change the clinical trials landscape within the lifesciences sector. As AI increasingly becomes a cornerstone in clinical research and drug development, it is crucial for industry stakeholders to grasp the extensive implications of this regulation. first appeared on CLOUDBYZ.
Yang Liu, PhD Founder, Chairman, CEO and Chief Scientific Officer OncoC4 Dr. Liu is recognized internationally for his research on immune recognition of cancer and activation of lymphocytes. Subscribe to the Xtalks LifeScience Podcast to never miss a new episode.
In the dynamic world of lifesciences, where innovation is paramount, the integration of cutting-edge technologies is crucial for accelerating clinical operations and driving breakthroughs in healthcare. Salesforce’s recent announcement of its LifeSciences Cloud marks a significant stride towards this goal.
Optum LifeSciences expert provides insights on the latest trends. Optum LifeSciencesresearchers stay up-to-date on the latest in research and how it may affect access for patients. Given the population level impact, what are researchers studying now? To learn more, contact Optum LifeSciences.
Most of us have heard of ChatGPT and AI but where and how do they fit into the lifesciences ecosystem? Over the next two years, GlobalData’s thematic research unit shows further advancements in machine learning, falling into three main categories: technology, macroeconomic, and regulatory.
Moderna has signed an agreement with IBM to explore quantum computing and generative artificial intelligence (AI) for advancing and expediting its mRNA research. IBM will also provide its knowledge to help Moderna explore the potential use cases of quantum technologies in lifesciences.
David Young, PharmD, PhD President, Research & Development Processa Pharmaceuticals Dr. Young is Processa’s initial founder, President of R&D and former President and CEO. He has over 30 years of pharmaceutical research, drug development and corporate experience. Young discussed with Xtalks in this podcast episode.
Tune into the episode to hear more about the latest trial data for finerenone in heart failure and the landscape of heart failure research. Subscribe to the Xtalks LifeScience Podcast to never miss a new episode. If you want your company to be featured on Xtalks.com, please email ayeshar@xtalks.com.
In the evolving landscape of clinical research, the data held in primary care Electronic Health Records (EHR) has been recognised for the significant potential it offers in uncovering insights, driving innovation, and enhancing patient care.
Panagos, an industry veteran with extensive experience in the healthcare and lifesciences sector, takes over from Colin Shannon, who served as CEO for one year following the company’s acquisition by a consortium of private equity firms. Shannon has now been appointed Executive Chairman of Syneos.
Subscribe to the Xtalks LifeScience Podcast to never miss a new episode. Tune in to learn how CTTI is leading efforts to reshape clinical trials. The weekly podcast is available for streaming every Wednesday on Spotify , Apple Music and wherever you stream your podcasts.
Tania Kamphaus and Tony Villiotti about new research on the utility and promise of blood-based biomarker tests for the diagnosis of liver diseases like non-alcoholic steatohepatitis (NASH). The research, published in Nature Medicine , presents results from a study that evaluated blood-based biomarker tests for the diagnosis of NASH.
Across every corner of the industry, from research and development to patient engagement, AI, and most recently generative AI (GenAI), is driving profound change.
Established in 2018, CytoMed is a biotechnology firm that originated from the Agency for Science, Technology and Research (A*STAR), Singapore’s premier public sector research and development agency. Subscribe to the Xtalks LifeScience Podcast to never miss a new episode.
McLeod received his Doctorate in Pharmacy from the Philadelphia College of Pharmacy and Science and completed his Post-Doctoral Training at St Jude Children’s Research Hospital and the University of Glasgow. Subscribe to the Xtalks LifeScience Podcast to never miss a new episode.
These organisations include 12 lifescience companies, 11 NIH institutes and centres, and ten non-profit organisations. The AMP was launched in 2014 as a partnership between the FDA , the National Institutes for Health, and several public and private organisations.
Tania Kamphaus and Tony Villiotti about new research on the utility and promise of blood-based biomarker tests for the diagnosis of liver diseases like non-alcoholic steatohepatitis (NASH). The research, published in Nature Medicine , presents results from a study that evaluated blood-based biomarker tests for the diagnosis of NASH.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content